Cite

HARVARD Citation

    Jensen, B. et al. (2017). Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non‐targeted metabolomics analysis. British journal of pharmacology. pp. 4797-4811. [Online]. 
  
Back to record